Literature DB >> 19602664

Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Sara J Houlihan1, Scot H Simpson, Andrew J Cave, Nigel W Flook, Mary E Hurlburt, Chris J Lord, Linda L Smith, Harvey H Sternberg.   

Abstract

OBJECTIVE: To characterize hypertension management in an academic family medicine clinic.
DESIGN: Cross-sectional chart review.
SETTING: Academic family medicine clinic in Edmonton, Alta. PARTICIPANTS: A total of 210 patients with 1 or more visits for hypertension during the previous 3 years. MAIN OUTCOME MEASURES: Patient characteristics, current antihypertensive therapies, most recent blood pressure measurements, and compelling indications according to the 2006 Canadian Hypertension Education Program recommendations.
RESULTS: A total of 185 subjects (88%) were prescribed antihypertensive medications, and 89 (42%) had controlled hypertension. Younger subjects, people with diabetes, and people not receiving antihypertensive medication therapy appeared less likely to have controlled hypertension. There were 76 subjects (36%) prescribed 1 antihypertensive medication, 65 subjects (31%) prescribed 2 antihypertensive medications, and 44 (21%) prescribed 3 or more antihypertensive medications. Angiotensin-converting enzyme inhibitors were prescribed for 51% of the subjects, diuretics for 47%, beta-blockers for 27%, calcium channel blockers for 23%, angiotensin receptor blockers for 20%, and alpha-blockers for 1%.
CONCLUSION: Hypertension treatment and control rates in this academic family medicine clinic appear to be better than those in the general population. Following the principles of a continuous quality improvement process, this information will serve as an important foundation for identifying areas to improve hypertension management in the clinic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602664      PMCID: PMC2718609     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

Review 2.  A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors:  K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Awareness, treatment, and control of hypertension in Canada.

Authors:  M R Joffres; P Ghadirian; J G Fodor; A Petrasovits; A Chockalingam; P Hamet
Journal:  Am J Hypertens       Date:  1997-10       Impact factor: 2.689

5.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

6.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

7.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25

8.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

Review 9.  Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.

Authors:  Marie Krousel-Wood; Sheila Thomas; Paul Muntner; Donald Morisky
Journal:  Curr Opin Cardiol       Date:  2004-07       Impact factor: 2.161

10.  Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.

Authors:  Carel F Schaars; Petra Denig; Willeke N Kasje; Roy E Stewart; Bruce H R Wolffenbuttel; Flora M Haaijer-Ruskamp
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

View more
  6 in total

1.  Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role?

Authors:  Jeffrey Chow; Tammy J Bungard
Journal:  Can Pharm J (Ott)       Date:  2013-09

2.  Hypertension and the family physician.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

3.  Hypertension management by family physicians: is it time to pat ourselves on the back?

Authors:  Karen Tu
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

4.  Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure--an observational study.

Authors:  Wayne Putnam; Beverley Lawson; Farokh Buhariwalla; Mary Goodfellow; Rose Anne Goodine; Jennifer Hall; Kendrick Lacey; Ian MacDonald; Frederick I Burge; Nandini Natarajan; Ingrid Sketris; Beth Mann; Peggy Dunbar; Kristine Van Aarsen; Marshall S Godwin
Journal:  BMC Fam Pract       Date:  2011-08-11       Impact factor: 2.497

5.  Individual awareness and treatment effectiveness of hypertension among older adults in Ghana: evidence from the World Health Organization study of global ageing and adult health wave 2.

Authors:  Benedict Calys-Tagoe; Benjamin D Nuertey; John Tetteh; Alfred Edwin Yawson
Journal:  Pan Afr Med J       Date:  2020-11-24

6.  Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.

Authors:  Nafees Ahmad; Amer Hayat Khan; Irfanullah Khan; Amjad Khan; Muhammad Atif
Journal:  Int J Hypertens       Date:  2018-03-12       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.